Molecular Endocrinology, doi:10.1210/me.2004-0487
Molecular Endocrinology 19 (7): 1837-1848
Copyright © 2005 by The Endocrine Society
Follicle-Stimulating Hormone Induction of Ovarian Insulin-Like Growth Factor-Binding Protein-3 Transcription Requires a TATA Box-Binding Protein and the Protein Kinase A and Phosphatidylinositol-3 Kinase Pathways
Elimelda Moige Ongeri,
Michael F. Verderame and
James M. Hammond
Pennsylvania State University, College of Medicine, Department of Medicine, Hershey Medical Center, Hershey, Pennsylvania 17033
Address all correspondence and requests for reprints to: James M. Hammond, Pennsylvania State University, College of Medicine, Hershey Medical Center, 500 University Drive, Hershey, Pennsylvania 17033. E-mail: jhammond{at}psu.edu.
The current study was done to elucidate the mechanism of the FSH stimulation of IGF-binding protein 3 (IGFBP-3) expression and map the FSH response element on the pig IGFBP-3 promoter. Forskolin induced IGFBP-3 reporter activity in transiently transfected granulosa cells. The protein kinase A (PKA) inhibitor [N-[2-(p-bromocinnamyl)amino)ethyl]-5-isoquinolinesulfonamide, 2HCl] (and cotransfection with a PKA inhibitor expression vector), the phosphatidylinositol-3 kinase inhibitor [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one], and the ERK inhibitor [1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene], all blocked FSH stimulation. Use of serial deletion constructs and site-directed mutagenesis show that a TATA box-binding protein site is required for FSH stimulation and that a specific protein 1 (Sp1) site is required for basal transcription. Gel shift assays of nuclear protein with a 61/25 probe detected four protein-DNA complexes, with bands I and II having significantly higher intensities in FSH-treated cells than in controls. Mutation of the Sp1 site prevented formation of bands I and II whereas mutation of the TATA box-binding protein site prevented formation of band IV. Use of specific antibodies showed that Sp1 participates in formation of band I, Sp3 band II, and p300 in both I and II. Band III was nonspecifically competed out. We conclude that FSH stimulation of IGFBP-3 transcription is mediated by cAMP via the PKA pathway and requires the P13 kinase and likely the MAPK pathways.
This article has been cited by other articles:

|
 |

|
 |
 
S.-W. M. Koh, K. Chandrasekara, C. J. Abbondandolo, T. J. Coll, and A. R. Rutzen
VIP and VIP Gene Silencing Modulation of Differentiation Marker N-Cadherin and Cell Shape of Corneal Endothelium in Human Corneas Ex Vivo
Invest. Ophthalmol. Vis. Sci.,
August 1, 2008;
49(8):
3491 - 3498.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Paquette, B. Bessette, E. Ledru, and C. Deal
Identification of Upstream Stimulatory Factor Binding Sites in the Human IGFBP3 Promoter and Potential Implication of Adjacent Single-Nucleotide Polymorphisms and Responsiveness to Insulin
Endocrinology,
December 1, 2007;
148(12):
6007 - 6018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-L. Yao, Y.-C. Lin, P. Sawhney, and J. H. Richburg
Transcriptional Regulation of FasL Expression and Participation of sTNF-{alpha} in Response to Sertoli Cell Injury
J. Biol. Chem.,
February 23, 2007;
282(8):
5420 - 5431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J M Silva, M Hamel, M Sahmi, and C A Price
Control of oestradiol secretion and of cytochrome P450 aromatase messenger ribonucleic acid accumulation by FSH involves different intracellular pathways in oestrogenic bovine granulosa cells in vitro.
Reproduction,
December 1, 2006;
132(6):
909 - 917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F.-y. Gong, Y.-f. Shi, and J.-y. Deng
The regulatory mechanism by which interleukin-6 stimulates GH-gene expression in rat GH3 cells.
J. Endocrinol.,
August 1, 2006;
190(2):
397 - 406.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by The Endocrine Society